Replies to post #298154 on Amarin Corp Plc (AMRN)

[Triple88]

HDG

If there is no recommendation this week what do you expect the LoQI key issues to be for EU?



Thanks

[Biobillionair]

G-

I expect LoOI.

Correct...now more about TEVA & Hikma....

We find out which direction this goes by MN 9-17 in PACER docket. You highlight TEVA royalty so you are aware there’s a deal with undisclosed terms regarding when TEVA and Amarin become partners...it is not “if”.

US market is generic but is it immediately Amarin/TEVA authorized generic if Hikma launches at risk by 11-17-2020 or does Hikma “settle” to compete with Amarin/TEVA after R-I exclusivities is up? Hikma is screwed either way.....

BB